IP Library › Granted Patent US 10,004,762
Granted Patent B2
US 10,004,762 · App. 14/787,293 · Granted Jun 26, 2018

Dialysis formulation

Inventors: Anna Bryland (Lomma, SE); Ola Carlsson (Lund, SE); Karin Sandin (Södra Sandby, SE)
Assignee: GAMBRO LUNDIA AB
A61K33/00A61K31/194A61K33/04A61K33/08A61K33/24A61K33/30A61K33/32A61K33/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,004,762
App. No.
14/787,293
Granted
Jun 26, 2018
Kind
B2
Abstract

The invention relates to a dialysis formulation, optionally a citrate containing dialysis formulation, comprising selenium (Se), optionally in combination with further trace elements selected from rubidium (Rb), cobalt (Co), molybdenum (Mo), and zinc (Zn). The dialysis formulation is intended to be used in dialysis treatment.

Claims (11)

1. A dialysis formulation comprising:

selenium (Se) in a concentration of 0.5-2.5 μM; and

rubidium (Rb) in a concentration of 0.1-4.7 μM, the dialysis formulation being essentially free of one or more of the trace elements selected from chromium (Cr), manganese (Mn) and copper (Cu).

2. A dialysis formulation according to claim 1 , wherein the dialysis formulation is a citrate containing formulation.

3. A dialysis formulation according to claim 1 , wherein the dialysis formulation further comprises one or more trace elements selected from the group of cobalt (Co), molybdenum (Mo), and zinc (Zn).

4. A dialysis formulation according to claim 1 , wherein selenium is in form of selenite.

5. The dialysis formulation of claim 1 comprising 0.6-1.8 μM of selenium.

6. The dialysis formulation of claim 1 comprising 1-1.5 μM of selenium.

7. The dialysis formulation of claim 1 comprising 1.4-4.2 μM of rubidium.

8. The dialysis formulation of claim 1 comprising 1.6-2.5 μM of rubidium.

9. A method of performing a dialysis therapy, the method comprising use of the dialysis formulation as defined in claim 1 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2015
From: BRYLAND, ANNA; CARLSSON, OLA; SANDIN, KARIN
To: GAMBRO LUNDIA AB
Reel/Frame 036904/0681 →
Priority Claims (2)
SE 1350573 · May 8, 2013 · national
SE 1350574 · May 8, 2013 · national
Continuity (1)
Related Publication 20160067278A1 · Mar 10, 2016